These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23639708)

  • 1. Pathogenesis of aspirin-exacerbated respiratory disease and reactions.
    Laidlaw TM; Boyce JA
    Immunol Allergy Clin North Am; 2013 May; 33(2):195-210. PubMed ID: 23639708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Steinke JW; Payne SC; Borish L
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease.
    Cahill KN; Laidlaw TM
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):681-691. PubMed ID: 27712763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of chronic urticaria exacerbation by aspirin.
    Mastalerz L; Setkowicz M; Szczeklik A
    Curr Allergy Asthma Rep; 2005 Jul; 5(4):277-83. PubMed ID: 15967068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
    Cahill KN; Bensko JC; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2015 Jan; 135(1):245-52. PubMed ID: 25218285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs.
    Kim SH; Sanak M; Park HS
    Immunol Allergy Clin North Am; 2013 May; 33(2):177-94. PubMed ID: 23639707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease.
    Crofford LJ
    Arthritis Res Ther; 2003; 5(1):25-7. PubMed ID: 12716444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.
    Dahlin A; Weiss ST
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):765-789. PubMed ID: 27712769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Special features of NSAID intolerance in children].
    Porto Arceo JA
    Allergol Immunopathol (Madr); 2003; 31(3):109-25. PubMed ID: 12783761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin E2: metabolism, determination in body fluids and the role in aspirin hypersensitivity].
    Gawlewicz-Mroczka A; Gielicz A; Mastalerz L; Szczeklik A
    Pol Arch Med Wewn; 2006 Jun; 115(6):578-86. PubMed ID: 17263231
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical updates in aspirin-exacerbated respiratory disease.
    Laidlaw TM
    Allergy Asthma Proc; 2019 Jan; 40(1):4-6. PubMed ID: 30582489
    [No Abstract]   [Full Text] [Related]  

  • 15. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
    Williams AN
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of aspirin sensitivity.
    Picado C
    Curr Allergy Asthma Rep; 2006 May; 6(3):198-202. PubMed ID: 16579869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of aspirin-exacerbated respiratory disease.
    Stevenson DD; Zuraw BL
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):169-88. PubMed ID: 12668897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
    Wang XS; Wu AY; Leung PS; Lau HY
    Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.